Cargando…
A Protocol for the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN): an open-label, randomised controlled trial
INTRODUCTION: Mycophenolate sodium, an enteric-coated tablet (EC-MPS), is as effective and safe as mycophenolate mofetil (MMF) in preventing transplant rejection. EC-MPS and MMF improve the outcome of severe lupus nephritis (LN) and have fewer side effects than pulsed intravenous cyclophosphamide. B...
Autores principales: | Ranganathan, Dwarakanathan, John, George T, Healy, Helen, Roberts, Matthew J, Fassett, Robert G, Lipman, Jeffrey, Kubler, Paul, Ungerer, Jacobus, McWhinney, Brett C, Lim, Aaron, Purvey, Megan, Reyaldeen, Reza, Roberts, Jason A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3740249/ https://www.ncbi.nlm.nih.gov/pubmed/23929919 http://dx.doi.org/10.1136/bmjopen-2013-003511 |
Ejemplares similares
-
Pharmacokinetics of Enteric-Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN)
por: Ranganathan, Dwarakanathan, et al.
Publicado: (2019) -
Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022) -
Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008) -
Mycophenolate versus Cyclophosphamide for Lupus Nephritis
por: Sahay, M., et al.
Publicado: (2018) -
Treatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case–control study
por: Li, Cui, et al.
Publicado: (2017)